MannKind Corporation.
biopharmaceutical company
- Reports this week
- 0
- Active events
- 1
- Connections
- 37
What's happening
Active this week
Earlier this month
One to three months ago
-
MannKind Corporation filed required documents with the SEC and its stock traded on the Nasdaq exchange.Some support2 reports
-
MannKind Corporation (or its related entity, MeiraGTx Holdings PLC) listed on the electronic stock exchange on September 1, 2026.Some support1 report
-
MannKind Corporation has a site in Westlake Village.Some support2 reports
-
Cipla achieved generic Ventolin approval in the US and partnered with MannKind Corporation for inhaled insulin.Well supported3 reports
-
MannKind Corporation must file a registration statement with the SEC, and FDA approval has triggered contingent value rights payment.Some support3 reports
Gone quiet
No new reports in 90+ days-
Stuart A. Tross was appointed Chief People & Workplace Officer at MannKind Corporation.Some support1 report
-
The CEO of MannKind Corporation filed Form 4 with the SEC regarding stock disposition on July 19, 2026.Some support1 report
-
MannKind Corporation began using LinkedIn for public communication.Some support2 reports
-
Leerink Partners reduced the price target for MannKind Corporation on June 25, 2025.Speculative1 report
-
MannKind Corporation focused on the U.S. market for pharmaceuticals in July 2025.Some support1 report1 development inside
-
Wells Fargo gave a Buy rating on MannKind Corporation on July 11, 2025.Some support1 report
-
MannKind Corporation, Tyvaso DPI, and Afreezza are expected to benefit from Trump-era tariffs and onshoring trends.Some support1 report
-
MannKind Corporation secured a strategic financing agreement involving Blackstone Inc. on August 6, 2025.Some support1 report
-
Zacks provided stock analysis and estimates for MannKind Corporation on August 6, 2025.Some support1 report
-
A company submitted a Biologics License Application to the FDA.Some support2 reports
-
Leerink partners reiterated a Buy rating on the stock of MannKind Corporation on August 26, 2025.Some support2 reports
-
Downward earnings revisions were announced for First Internet Bank of Indiana and MannKind Corporation on August 27, 2025.Some support1 report
-
MannKind Corporation began using LinkedIn for company presence, with Chris Prentiss serving as Chief Financial Officer.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around MannKind Corporation this week
News at the entities that move MannKind Corporation most-
SEC StructuralSoFi disclosed a transaction in a legal filing with the SEC and its stock is traded on Nasdaq.Moves MannKind Corporation
-
FDA StructuralVera Therapeutics and the FDA agreed to shift the assessment of a clinical study.Moves MannKind Corporation
-
Nasdaq StructuralApple Inc. debuted its new foldable smartphone on September 10, 2026.Moves MannKind Corporation
-
United Therapeutics OperationalUnited Therapeutics completed facility construction in Minnesota and Texas and submitted an NDA to the FDA.Moves MannKind Corporation
-
Securities and Exchange Commission StructuralThe Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.Moves MannKind Corporation
-
Donald Trump OperationalTrump invokes the Defense Production Act to boost domestic energy production.Moves MannKind Corporation
Connections
The 16 strongest of 37, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Castagna Structural
Castagna serves as the Chief Executive Officer of MannKind Corporation.
-
Chris Prentiss Structural
Chris Prentiss serves as the Chief Financial Officer for MannKind Corporation.
-
FDA Structural
MannKind Corporation's market access and product lifecycle are governed by the formal regulatory oversight and approval processes of the FDA.
-
United Therapeutics Operational
The companies are engaged in an ongoing partnership involving joint drug development, supply of clinical trial materials, and a shared royalty stream.
-
Nasdaq Structural
MannKind Corporation maintains its market presence by being listed on the Nasdaq stock exchange.
-
Ajay Ahuja Structural
Ajay Ahuja holds the role of Chief Medical Officer at MannKind Corporation.
-
Donald Trump Operational
MannKind Corporation's financial performance is observed to benefit from the tariffs and onshoring trends associated with Donald Trump's era.
-
Cipla Transactional
The two companies have formed a partnership to jointly develop and market inhaled insulin.
Show all 16 connections
-
Securities and Exchange Commission Structural
MannKind Corporation is subject to formal regulatory requirements, including filing statements, mandated by the Securities and Exchange Commission.
-
Conor Daly Transactional
MannKind Corporation engages in a sponsorship and partnership relationship with Conor Daly for marketing and diabetes awareness.
-
Breakthrough Transactional
Breakthrough granted a grant to MannKind Corporation to support a clinical study.
-
Leerink partners Mentioned together
Leerink Partners provides financial ratings and price targets for MannKind Corporation.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provides institutional research and ratings coverage on MannKind Corporation.
-
SEC Structural
MannKind Corporation is subject to mandatory regulatory oversight by the SEC, evidenced by required stock transaction disclosure filings.
-
Westlake Village Shared context
MannKind Corporation maintains a site within Westlake Village.
-
MarketBeat Mentioned together
MarketBeat publishes and aggregates analyst ratings and data concerning MannKind Corporation.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
3 events- MannKind Corporation stock trades on the Nasdaq electronic exchange, with market data reported by MarketBeat.
- MannKind Corporation filed required documents with the SEC and its stock traded on the Nasdaq exchange.
- MannKind Corporation (or its related entity, MeiraGTx Holdings PLC) listed on the electronic stock exchange on September 1, 2026.
July 2026
5 events- MannKind Corporation has a site in Westlake Village.
- Cipla achieved generic Ventolin approval in the US and partnered with MannKind Corporation for inhaled insulin.
- MannKind Corporation must file a registration statement with the SEC, and FDA approval has triggered contingent value rights payment.
- Stuart A. Tross was appointed Chief People & Workplace Officer at MannKind Corporation.
- The CEO of MannKind Corporation filed Form 4 with the SEC regarding stock disposition on July 19, 2026.
Show 1 earlier month
June 2026
12 events- MannKind Corporation met with the FDA regarding its plan file for approval.
- MannKind Corporation began using LinkedIn for public communication.
- Leerink Partners reduced the price target for MannKind Corporation on June 25, 2025.
- MannKind Corporation focused on the U.S. market for pharmaceuticals in July 2025.
- Wells Fargo gave a Buy rating on MannKind Corporation on July 11, 2025.
- MannKind Corporation, Tyvaso DPI, and Afreezza are expected to benefit from Trump-era tariffs and onshoring trends.
- MannKind Corporation secured a strategic financing agreement involving Blackstone Inc. on August 6, 2025.
- Zacks provided stock analysis and estimates for MannKind Corporation on August 6, 2025.
- A company submitted a Biologics License Application to the FDA.
- Leerink partners reiterated a Buy rating on the stock of MannKind Corporation on August 26, 2025.
- Downward earnings revisions were announced for First Internet Bank of Indiana and MannKind Corporation on August 27, 2025.
- MannKind Corporation began using LinkedIn for company presence, with Chris Prentiss serving as Chief Financial Officer.